Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer: a Single-Center Experience

Onderzoeksoutput › Academic

Originele taal-2	English
Pagina's (van-tot)	S849-S849
Aantal pagina's	1
Tijdschrift	Journal of Thoracic Oncology
Volume	16
Nummer van het tijdschrift	10
Status	Published - okt.-2021

Handle.net

@article{2464cbb515cb4a179be63ada5588b10b,

title = "Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer: a Single-Center Experience",

keywords = "NSCLC, covid-19, immune checkpoint inhibitor",

author = "L. Hijmering-Kappelle and Hiltermann, {T. J. N.} and F. Bensch",

year = "2021",

month = oct,

language = "English",

volume = "16",

pages = "S849--S849",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "ELSEVIER SCIENCE INC",

number = "10",

}

TY - JOUR

T1 - Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer

T2 - a Single-Center Experience

AU - Hijmering-Kappelle, L.

AU - Hiltermann, T. J. N.

AU - Bensch, F.

PY - 2021/10

Y1 - 2021/10

KW - NSCLC

KW - covid-19

KW - immune checkpoint inhibitor

M3 - Meeting Abstract

SN - 1556-0864

VL - 16

SP - S849-S849

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 10

ER -